CBmed, an Austrian funded competence center, links excellent research infrastructure, scientific expertise, medical knowledge, national and international industry partners for systematic medical biomarker research. Based in Graz (Austria), CBmed brings together scientific experts with leading pharmaceutical, diagnostic, medical-technology and IT industry partners. In addition, CBmed has a strong network in the area of Biobanking including the largest Biobank in Europe, Biobank Graz, and the European Biobanking network BBMRI-ERIC. CBmed research projects will identify new biomarkers, validate potential biomarkers and conduct translational biomarker research for products to be used in clinical practice. CBmed will develop easily applicable, targeted, minimally invasive biomarkers for better diagnosis, better therapy monitoring and a more personalized treatment of patients. The vision of the company is to enable applied precision medicine, driven by scientific excellence and global partnerships for patient care and cure. This will be achieved by integrating cutting-edge technologies with international and interdisciplinary expertise in the research fields of cancer and microbiome. Together with our scientific and industry partners, we will develop solutions and products for patient care and cure.
